Kyverna Therapeutics (KYTX)'s 30-day implied volatility (IV30) was 71.8% at the close on October 16, 2026, up from 59.4% the day before, against a 52-week range of 58.4% to 168.2%. Its 20-day historical volatility was 70.5%.
Data as of October 16, 2026.